Pharma Quality Systems and Compliance
Strong and robust quality systems are required for companies to consistently and reliably produce safe, high-quality products and services. Not addressing concerns highlighted in FDA 483s and FDA warning letters can potentially halt production or, worse, result in a recall, import bans, detention or product seizure, which can damage your organization s pipeline, financial well-being and reputation. With relentless, often subtle, changes to guidelines released by regulatory authorities around the world, it can be challenging to stay up to date. With substantial experience in creating, implementing, reviewing and remediating quality systems for a variety of organizations, NSF Health Sciences Pharma Biotech is the premier source for assistance with any question or issue related to quality systems.
We utilize a systems-based approach to compliance covering the major pharmaceutical subsystems including:
- Quality system
- Laboratory controls
- Material controls
- Facilities and equipment
- Production system
- Packaging and labeling
NSF meets your compliance and quality systems needs. Learn More
Our GLP/GMP contract lab provides accurate and reliable testing. Learn More
FDA REGULATORY AND COMPLIANCE NEWS FDA announced availability of a guidance for industry entitled, Microbiology Data for Systemic Antibacterial Drugs.
On July 27, 2016, Peter Gough, Executive Director of NSF Health Sciences Pharma Biotech, was awarded an honorary Doctor of.
FDA REGULATORY AND COMPLIANCE NEWS FDA s Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee voted.
- Monday, September 12, 2016
- 8:30am – 3:00pm GMT
- Newcastle upon Tyne, United Kingdom
- Wednesday, September 14, 2016
- 9:00am – 4:00pm GMT
- Manchester, United Kingdom
- Monday, September 19, 2016
- 8:30am – 5:00pm GMT
- York, United Kingdom
- Monday, September 26, 2016
- 1:00pm – 1:30pm GMT
- Webinar, United Kingdom